During the past decade, UVA CARE conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UVA CARE" #1 sponsor was "University of Virginia" with 6 trials, followed by "Bankole Johnson" with 4 trials sponsored, "Blue Earth Diagnostics" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UVA CARE" #1 collaborator was "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Biohaven Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "UVA CARE" are "Alcoholism" (3 trials), "Alcohol Dependence" (2 trials), "Prostate Cancer" (2 trials), "Advanced Solid Tumors" (1 trials) and "Alcohol Exposed Pregnancy" (1 trials). Many other conditions were trialed in "UVA CARE" in a lesser frequency.

Most popular intervention types in "UVA CARE" are "Drug" (20 trials), "Other" (3 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Topiramate" (3 trials), "Placebo + Cognitive Behavioral Therapy" (2 trials), "rhPSMA-7.3 (18F) Injection" (2 trials) and "ARRY-382" (1 trials). Other intervention names were less common.

The vast majority of trials in "UVA CARE" are 20 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "UVA CARE". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in UVA CARE, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UVA CARE, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".